DAWN
Day One Biopharmaceuticals Inc
NASDAQ: DAWN · HEALTHCARE · BIOTECHNOLOGY
$21.53
+0.00% today
Updated 2026-04-23
Market cap
$2.22B
P/E ratio
—
P/S ratio
14.06x
EPS (TTM)
$-1.04
Dividend yield
—
52W range
$6 – $22
Volume
4.5M
Day One Biopharmaceuticals Inc (DAWN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.51M | $-13.49M | $-48.54M | $-109.87M | $-146.85M | $-78.11M | $-103.76M |
| Capital expenditures | $92000.00 | $92000.00 | $8.00M | $26000.00 | $3.22M | $2.17M | $320000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $111000.00 | $526000.00 | $13.32M | $27.24M | $39.34M | $48.26M | $44.39M |
| Free cash flow | $-4.61M | $-13.58M | $-56.54M | $-109.90M | $-150.08M | $-80.28M | $-104.08M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $240.58M | $-199.05M | — | — | — |